ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Metabolic disease"

  • 2020 American Transplant Congress

    Selectively Transplanting Moderately to Severely Macrosteatotic Grafts: Does Recipient Metabolic Environment Affect Outcomes?

    P. J. Altshuler, A. Rios Diaz, O. Shaheen, A. P. Shah, W. R. Maley, A. Frank, C. Ramirez, J. Glorioso, H. Dang, A. S. Bodzin

    Department of Surgery, Thomas Jefferson University, Philadelphia, PA

    *Purpose: As incidence of Non-Alcoholic Steatohepatitis (NASH) cirrhosis rises, organ utilization remains stagnant. Recently, it has been shown that selective utilization of >30% macrosteatotic grafts…
  • 2020 American Transplant Congress

    Pediatric Liver Transplantation for Metabolic Liver Diseases versus Biliary Atresia: Single Center Experience

    A. M. Elsabbagh, K. M. Khan, A. A. Amin, S. S. Kaufman, N. A. Yazigi, T. M. Fishbein

    MedStar Georgetown Transplant Institute, Georgetown University Hospital, Washington, DC

    *Purpose: The main indication for LT in children has been biliary atresia (BA). Recent advances in surgical management and the development of new immunosuppressants have…
  • 2020 American Transplant Congress

    Functional Changes in Metabolic and Malignancy Associated Bacterial Genes in the Post Transplant Intestinal Microbiome

    M. Bhat1, S. Sivaraj1, E. Pasini1, J. Copeland2, J. Allard3, A. Humar1

    1Multi-Organ Transplant, UHN, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3UHN, Toronto, ON, Canada

    *Purpose: Long-term survival of liver transplant (LT) recipients is affected by metabolic and malignant complications. The aim of our study was to examine changes in…
  • 2020 American Transplant Congress

    Liver Transplantation for Pediatric Genetic and Metabolic Liver Disease: A Single-Center Experience

    S. Hassan1, K. Mysore1, D. N. Cerminara2, K. E. Hosek3, M. Faraone4, R. Sigereddi5, R. Ackah5, A. Rana6, J. Goss6, T. Galvan6

    1Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 2Pharmacy, Texas Children's Hospital, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 3Outcomes and Impact Service, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 4Department of Surgery, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 5Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 6Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX

    *Purpose: Pediatric liver transplantation (LT) is an established treatment for a myriad of liver diseases most notably biliary atresia and urea cycle defects. In the…
  • 2020 American Transplant Congress

    Long-Term Pediatric Outcomes of Simultaneous vs. Sequential Liver-Kidney Transplantation: A Review of the UNOS Database

    K. Goli1, A. Rana1, J. Goss1, T. Miloh2

    1Baylor College of Medicine/Texas Children's Hospital, Houston, TX, 2University of Miami, Houston, TX

    *Purpose: The long-term pediatric outcomes of simultaneous liver-kidney (SLK) transplantation and sequential liver and kidney transplantation, liver after kidney (LAK) and kidney after liver (KAL),…
  • 2019 American Transplant Congress

    Extremes of Body Mass Index is Associated with Inferior Renal Allograft Outcomes in Type 2 Diabetic Deceased Donor Renal Transplant Recipients

    A. Brar, A. Gruessner, F. Tedla, R. Gruessner, J. Renz, N. Sumrani, D. John, M. O. Salifu

    SUNY Downstate Medical Center, Brooklyn, NY

    *Purpose: We evaluated the trends and renal allograft outcomes in type 2 diabetic renal transplant recipients stratified by body mass index (BMI).*Methods: All adult type…
  • 2019 American Transplant Congress

    A Novel Program of Directed Domino and Split Liver Donations Increases Liver Transplants

    T. Fishbein, C. Matsumoto, N. Yazigi, R. Satoskar, S. Kaufman, K. Khan, K. Alexander, J. Hawksworth, M. Summer

    Medstar Georgetown Transplant Institute, Georgetown University Hospital, Washington, DC

    *Purpose: Liver transplants have not been performed in directed donor chains as have evolved for kidney transplants. We report an initial experience using domino and…
  • 2019 American Transplant Congress

    The Efficacy of Spheroidal Hepatocytes for Hepatocyte Transplantation

    K. Shibuya, M. Watanabe, Y. Ganchiku, R. Kanazawa, Y. Koshizuka, M. Zaitsu, R. Goto, A. Taketomi

    Department of Gastroenterological Surgery Ⅰ Hokkaido University Graduate School, Sapporo, Japan

    *Purpose: Hepatocyte transplantation (HCTx) is expected to expand its application as a next generation therapy alternative to liver transplantation. Following HCTx, the liver function improves…
  • 2019 American Transplant Congress

    Orthotopic Liver Transplantation in MPV17 Deficiency: A Case Series

    E. A. Gerzina1, E. D. Witte1, M. L. Kueht2, R. W. Himes3

    1Baylor College of Medicine, Houston, TX, 2Department of Surgery, Division of Abdominal Transplant, Baylor College of Medicine, Houston, TX, 3Pediatrics--Gastroenterology, Baylor College of Medicine, Houston, TX

    *Purpose: The purpose of this study was to consider the clinical courses of two patients with MPV17 mutations and to evaluate the efficacy of liver…
  • 2019 American Transplant Congress

    Metabolomic Study Of Sarcopenia In Patients Prior To Liver Transplantation

    S. Ries,1, N. J. Skill1, E. Campbell1, R. Daniel2, C. A. Kubal1, M. S. Richard1, M. A. Maluccio1

    1Surgery, Indiana University, Indianapolis, IN, 2University of Washington, Seattle, WA

    *Purpose: Sarcopenia is defined as the loss of muscle mass, typically associated with aging, but frequently appearing in liver disease patients. In particular, sarcopenia present…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences